David C. Sachs Immunity Bio, Inc. (IBRX) insider trading activity
David C. Sachs is Chief Financial Officer of ImmunityBio, Inc.. Currently has a direct ownership of 200,830 shares of IBRX, which is worth approximately $618,556. The most recent transaction as insider was on Dec 31, 2024, when has been sold 15,405 shares (Common Stock) at a price of $2.56 per share, resulting in proceeds of $39,436. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
201K
8.07%
3M change
41.5%
12M change
Total Value Held
$618,556
David C. Sachs Transaction History
DCS
David C. Sachs
Chief Financial Officer
San Diego, CA